• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高胆固醇血症的管理

Management of hypercholesterolemia.

作者信息

Blake G H, Triplett L C

机构信息

University of Mississippi Medical Center, Jackson, USA.

出版信息

Am Fam Physician. 1995 Apr;51(5):1157-66, 1171-2.

PMID:7709892
Abstract

As a major risk factor for coronary heart disease, hypercholesterolemia is responsible for a significant number of illnesses and deaths, and contributes considerably to health care costs. Lowering cholesterol levels reduces the risk of coronary heart disease and may halt or reverse atherosclerosis. Lifestyle modifications include dietary measures and aerobic exercise. Pharmacologic therapy can further decrease cholesterol levels. Family physicians need to recognize patients at risk for hypercholesterolemia (and thus coronary heart disease), institute appropriate therapy and counsel family members about disease prevention.

摘要

作为冠心病的主要危险因素,高胆固醇血症导致了大量的疾病和死亡,并在很大程度上增加了医疗成本。降低胆固醇水平可降低冠心病风险,并可能阻止或逆转动脉粥样硬化。生活方式的改变包括饮食措施和有氧运动。药物治疗可进一步降低胆固醇水平。家庭医生需要识别有高胆固醇血症风险(进而有冠心病风险)的患者,实施适当的治疗,并就疾病预防向家庭成员提供咨询。

相似文献

1
Management of hypercholesterolemia.高胆固醇血症的管理
Am Fam Physician. 1995 Apr;51(5):1157-66, 1171-2.
2
[Summary of 'Cholesterol' guideline (first revision) of the Dutch Society of Family Physicians].[荷兰家庭医生协会《胆固醇》指南(首次修订版)总结]
Ned Tijdschr Geneeskd. 2000 Feb 26;144(9):421-7.
3
[Statins in primary prevention of coronary heart disease].[他汀类药物在冠心病一级预防中的应用]
Wien Med Wochenschr. 1999;149(5-6):129-38.
4
[Evidence of the efficacy of hypocholesterolemic treatment in primary and secondary prevention of ischemic heart disease].
Med Clin (Barc). 2000;114 Suppl 2:1-10.
5
[Cholesterol determination in ambulatory general practice within the scope of the Brugg/AG quality circle].[在布鲁格/AG质量圈范围内的门诊普通医疗中进行胆固醇测定]
Praxis (Bern 1994). 2000 Sep 7;89(36):1413-21.
6
The heart of the matter. National guidelines urge more aggressive cholesterol treatment.问题的核心。国家指南敦促更积极地进行胆固醇治疗。
Adv Nurse Pract. 2002 Jan;10(1):42-7; quiz 48-9.
7
Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.荟萃分析、临床试验以及研究结果向实践的可转化性。以冠心病二级预防中的降胆固醇干预措施为例。
Arch Intern Med. 1996 Jun 10;156(11):1158-72.
8
[Lipid therapy. Goal and use in prevention of coronary heart disease].
Internist (Berl). 1996 Dec;37(12):1244-8.
9
Hypercholesterolemia: a reversible risk factor for coronary heart disease.高胆固醇血症:冠心病的一个可逆转风险因素。
CMAJ. 1989 Feb 15;140(4):419.
10
[Hypercholesterolemia: to treat or not to treat? That is the question].[高胆固醇血症:治疗还是不治疗?这是个问题]
Rev Med Brux. 1994 May-Jun;15(3):124-31.

引用本文的文献

1
Cholesterol metabolism: molecular mechanisms, biological functions, diseases, and therapeutic targets.胆固醇代谢:分子机制、生物学功能、疾病及治疗靶点。
Mol Biomed. 2025 Oct 9;6(1):72. doi: 10.1186/s43556-025-00321-3.
2
Efficacy and outcomes of bempedoic acid versus placebo in patients with hypercholesterolemia: an updated systematic review and meta-analysis of randomized controlled trials.贝派地酸与安慰剂治疗高胆固醇血症患者的疗效及结局:随机对照试验的最新系统评价和荟萃分析
Cardiovasc Endocrinol Metab. 2024 Jun 20;13(3):e0302. doi: 10.1097/XCE.0000000000000302. eCollection 2024 Sep.
3
Hyperlipidemia and obesity among diabetics at jubail miiltary hospital.
朱拜勒军事医院糖尿病患者中的高脂血症和肥胖症
J Family Community Med. 1998 Jan;5(1):45-50.
4
Simvastatin. A reappraisal of its cost effectiveness in dyslipidaemia and coronary heart disease.辛伐他汀。对其在血脂异常和冠心病治疗中成本效益的重新评估。
Pharmacoeconomics. 1997 Jan;11(1):89-110. doi: 10.2165/00019053-199711010-00010.